Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal
The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics ' tech platform.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Information Technology | Schizophrenia